-transparent.png){kind=logo}
We present two natalizumab-treated multiple sclerosis patients who developed glioblastoma multiforme (GBM) with variable outcomes. One patient had an isocitrate dehydrogenase (IDH)-wildtype GBM with aggressive behavior, who declined treatment and died 13 weeks after symptoms onset. The other patient underwent resection of an IDH-mutant secondary GBM that arose from a previously diagnosed grade II astrocytoma. He is still alive 5 years after the diagnosis of GBM. JC virus was not detected in either case. Whether natalizumab played a role in the development of GBM in those patients deserves further investigation.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Fabian Sierra Morales, and
Robert B Wright, and
Jorge E Novo, and
Leonidas D Arvanitis, and
Dusan Stefoski, and
Igor J Koralnik
July 2016,
Multiple sclerosis and related disorders,
Fabian Sierra Morales, and
Robert B Wright, and
Jorge E Novo, and
Leonidas D Arvanitis, and
Dusan Stefoski, and
Igor J Koralnik
January 2016,
Multiple sclerosis journal - experimental, translational and clinical,
Fabian Sierra Morales, and
Robert B Wright, and
Jorge E Novo, and
Leonidas D Arvanitis, and
Dusan Stefoski, and
Igor J Koralnik
May 2006,
Annals of neurology,
Fabian Sierra Morales, and
Robert B Wright, and
Jorge E Novo, and
Leonidas D Arvanitis, and
Dusan Stefoski, and
Igor J Koralnik
October 2011,
Neurology,
Fabian Sierra Morales, and
Robert B Wright, and
Jorge E Novo, and
Leonidas D Arvanitis, and
Dusan Stefoski, and
Igor J Koralnik
January 2014,
European neurology,
Fabian Sierra Morales, and
Robert B Wright, and
Jorge E Novo, and
Leonidas D Arvanitis, and
Dusan Stefoski, and
Igor J Koralnik
June 2013,
The New England journal of medicine,
Fabian Sierra Morales, and
Robert B Wright, and
Jorge E Novo, and
Leonidas D Arvanitis, and
Dusan Stefoski, and
Igor J Koralnik
June 2010,
Journal of neurology,
Fabian Sierra Morales, and
Robert B Wright, and
Jorge E Novo, and
Leonidas D Arvanitis, and
Dusan Stefoski, and
Igor J Koralnik
September 2011,
Multiple sclerosis (Houndmills, Basingstoke, England),
Fabian Sierra Morales, and
Robert B Wright, and
Jorge E Novo, and
Leonidas D Arvanitis, and
Dusan Stefoski, and
Igor J Koralnik
May 2011,
Leukemia & lymphoma,
Fabian Sierra Morales, and
Robert B Wright, and
Jorge E Novo, and
Leonidas D Arvanitis, and
Dusan Stefoski, and
Igor J Koralnik
July 2013,
Clinical neurology and neurosurgery,
